Real-time monitoring of nfxB mutant occurrence and dynamics in Pseudomonas aeruginosa biofilm exposed to subinhibitory concentrations of ciprofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 61, Issue 3, 2017, Pages

  Zaborskyte, Greta ^a,b   Andersen, Jens Bo ^a   Kragh, Kasper Nørskov ^a   Ciofu, Oana ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biofilms; Ciprofloxacin; Pseudomonas aeruginosa

Indexed keywords

CIPROFLOXACIN; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MEMBRANE PROTEIN; MEXC PROTEIN, PSEUDOMONAS AERUGINOSA; MEXD PROTEIN, PSEUDOMONAS AERUGINOSA; NFXB PROTEIN, PSEUDOMONAS AERUGINOSA; OPRJ PROTEIN, PSEUDOMONAS AERUGINOSA; PHOTOPROTEIN; RED FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BACTERIAL CELL; BIOFILM; BIOMASS; CELL MUTANT; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DEVELOPMENTAL STAGE; FLUORESCENCE; IN VITRO STUDY; INHIBITORY CONCENTRATION; LOW DRUG DOSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; WILD TYPE; ANTIBIOTIC RESISTANCE; CONFOCAL MICROSCOPY; DRUG EFFECTS; FLOW KINETICS; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETIC SELECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION; REPORTER GENE; TIME LAPSE IMAGING;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOFILMS; CIPROFLOXACIN; DNA-BINDING PROTEINS; DRUG RESISTANCE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MUTATION; PSEUDOMONAS AERUGINOSA; RECOMBINANT FUSION PROTEINS; RHEOLOGY; SELECTION, GENETIC; TIME-LAPSE IMAGING; TRANSCRIPTION FACTORS;

EID: 85014074382     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02292-16     Document Type: Article

References (38)

1. Ciofu O, Tolker-Nielsen T, Jensen PØ, Wang H, Høiby N. 2015. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv Drug Deliv Rev 85:7-23. https://doi.org/10.1016/j.addr.2014.11.017.
2. Rybtke M, Hultqvist LD, Givskov M, Tolker-Nielsen T. 2015. Pseudomonas aeruginosa biofilm infections: community structure, antimicrobial tolerance and immune response. J Mol Biol 427:3628-3645. https://doi.org/10.1016/j.jmb.2015.08.016.
3. Fernández L, Hancock REW. 2012. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev 25:661-681. https://doi.org/10.1128/CMR.00043-12.
4. Poole K. 2011. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2:65. https://doi.org/10.3389/fmicb.2011.00065.
5. Boles BR, Singh PK. 2008. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc Natl Acad Sci U S A 105:12503-12508. https://doi.org/10.1073/pnas.0801499105.
6. Andersson DI, Hughes D. 2014. Microbiological effects of sublethal levels of antibiotics. Nat Rev Microbiol 12:465-478. https://doi.org/10.1038/nrmicro3270.
7. Blázquez J, Couce A, Rodríguez-Beltrán J, Rodríguez-Rojas A. 2012. Antimicrobials as promoters of genetic variation. Curr Opin Microbiol 15:561-569. https://doi.org/10.1016/j.mib.2012.07.007.
8. Høiby N, Ciofu O, Bjarnsholt T. 2010. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5:1663-1674. https://doi.org/10.2217/fmb.10.125.
9. Poole K. 2005. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56:20-51. https://doi.org/10.1093/jac/dki171.
10. Fraud S, Campigotto AJ, Chen Z, Poole K. 2008. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Antimicrob Agents Chemother 52:4478-4482. https://doi.org/10.1128/AAC.01072-08.
11. Li X-Z, Plésiat P, Nikaido H. 2015. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev 28:337-418. https://doi.org/10.1128/CMR.00117-14.
12. Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B. 2000. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother 44:710-712. https://doi.org/10.1128/AAC.44.3.710-712.2000.
13. Jeannot K, Elsen S, Köhler T, Attree I, Van Delden C, Plésiat P. 2008. Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Chemother 52:2455-2462. https://doi.org/10.1128/AAC.01107-07.
14. Monti MR, Morero NR, Miguel V, Argaraña CE. 2013. nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa. PLoS One 8:e66236. https://doi.org/10.1371/journal.pone.0066236.
15. Morero NR, Monti MR, Argaraña CE. 2011. Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators. Antimicrob Agents Chemother 55:3668-3676. https://doi.org/10.1128/AAC.01826-10.
16. Mulet X, Maciá MD, Mena A, Juan C, Pérez JL, Oliver A. 2009. Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants. Antimicrob Agents Chemother 53:1552-1560. https://doi.org/10.1128/AAC.01264-08.
17. Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL, Oliver A. 2006. Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:975-983. https://doi.org/10.1128/AAC.50.3.975-983.2006.
18. Macià MD, Pérez JL, Molin S, Oliver A. 2011. Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment. Antimicrob Agents Chemother 55:5230-5237. https://doi.org/10.1128/AAC.00617-11.
19. Crusz SA, Popat R, Rybtke MT, Cámara M, Givskov M, Tolker-Nielsen T, Diggle SP, Williams P. 2012. Bursting the bubble on bacterial biofilms: a flow cell methodology. Biofouling 28:835-842. https://doi.org/10.1080/08927014.2012.716044.
20. Almblad H, Harrison JJ, Rybtke M, Groizeleau J, Givskov M, Parsek MR, Tolker-Nielsen T. 2015. The cyclic AMP-Vfr signaling pathway in Pseudomonas aeruginosa is inhibited by cyclic di-GMP. J Bacteriol 197:2190-2200. https://doi.org/10.1128/JB.00193-15.
21. Scholz O, Thiel A, Hillen W, Niederweis M. 2000. Quantitative analysis of gene expression with an improved green fluorescent protein. Eur J Biochem 1570:1565-1570.
22. Stewart PS, Franklin MJ. 2008. Physiological heterogeneity in biofilms. Nat Rev Microbiol 6:199-210. https://doi.org/10.1038/nrmicro1838.
23. Purssell A, Poole K. 2013. Functional characterization of the NfxB repressor of the mexCD-oprJ multidrug efflux operon of Pseudomonas aeruginosa. Microbiology 159:2058-2073. https://doi.org/10.1099/mic.0.069286-0.
24. De Kievit T, Parkins M, Gillis R, Srikumar R, Ceri H, Poole K, Iglewski BH, Storey D. 2001. Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 45:1761-1770. https://doi.org/10.1128/AAC.45.6.1761-1770.2001.
25. Choi K-H, Schweizer HP. 2006. Mini-Tn7 insertion in bacteria with single attTn7 sites: example Pseudomonas aeruginosa. Nat Protoc 1:153-161. https://doi.org/10.1038/nprot.2006.24.
26. Justice SS, Hunstad DA, Cegelski L, Hultgren SJ. 2008. Morphological plasticity as a bacterial survival strategy. Nat Rev Microbiol 6:162-168. https://doi.org/10.1038/nrmicro1820.
27. Bos J, Zhang Q, Vyawahare S, Rogers E, Rosenberg SM, Austin RH. 2015. Emergence of antibiotic resistance from multinucleated bacterial filaments. Proc Natl Acad Sci U S A 112:178-183. https://doi.org/10.1073/pnas.1420702111.
28. Breidenstein EBM, Bains M, Hancock REW. 2012. Involvement of the lon protease in the SOS response triggered by ciprofloxacin in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother 56:2879-2887. https://doi.org/10.1128/AAC.06014-11.
29. Masuda N, Gotoh N, Ohya S, Nishino T. 1996. Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 40:909-913.
30. Jørgensen KM, Wassermann T, Jensen PØ, Hengzuang W, Molin S, Høiby N, Ciofu O. 2013. Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosa. Antimicrob Agents Chemother 57:4215-4221. https://doi.org/10.1128/AAC.00493-13.
31. Stickland HG, Davenport PW, Lilley KS, Griffin JL, Welch M. 2010. Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa. J Proteome Res 9:2957-2967. https://doi.org/10.1021/pr9011415.
32. Martínez-Ramos I, Mulet X, Moyá B, Barbier M, Oliver A, Albertí S. 2014. Overexpression of MexCD-OprJ reduces Pseudomonas aeruginosa virulence by increasing its susceptibility to complement-mediated killing. Antimicrob Agents Chemother 58:2426-2429. https://doi.org/10.1128/AAC.02012-13.
33. Wong A, Rodrigue N, Kassen R. 2012. Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa. PLoS Genet 8:e1002928. https://doi.org/10.1371/journal.pgen.1002928.
34. Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI. 2011. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog 7:e1002158. https://doi.org/10.1371/journal.ppat.1002158.
35. Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersbøll BK, Molin S. 2000. Quantification of biofilm structures by the novel computer program. Microbiology 146:2395-2407. https://doi.org/10.1099/00221287-146-10-2395.
36. Vorregaard M. 2008. Comstat2 - a modern 3D image analysis environment for biofilms. PhD thesis. Technical University of Denmark, Kongens Lyngby, Denmark.
37. Bao Y, Lies DP, Fu H, Roberts GP. 1991. An improved Tn7-based system for the single-copy insertion of cloned genes into chromosomes of gram-negative bacteria. Gene 109:167-168. https://doi.org/10.1016/0378-1119(91)90604-A.
38. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP. 1998. A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86. https://doi.org/10.1016/S0378-1119(98)00130-9.